{"retracted":false,"update":{"timestamp":1445472000000,"doi":"10.1371/journal.pone.0141704","type":"correction"},"doi":"10.1371/journal.pone.0136324","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"}
